John Dyett

John Dyett is a Co-Founder and serves as Managing Director at Salem Partners. He also serves as Board Member at OncoNano Medicine and Sebacia. Dyett heads the firm's efforts in the Life Sciences. He has raised in excess of $200 million of private equity and completed multiple merger and acquisition assignments for Salem Partners' clients. Dyett raised several rounds of venture capital for Adams Respiratory Therapeutics which was purchased for $2.3 billion cash by Reckitt Benckiser in 2008. Dyett's other clients include Neos Therapeutics, Lombardi Software and Quinnova Pharmaceuticals. Dyett also serves on the investment committees of Salem Partners Wealth Management and SW Contego, a fund of hedge funds established by Salem Partners Wealth Management in 2008. Prior to founding Salem Partners, Dyett was a banker with Gerard Klauer Mattison & Company and Needham and Coompany. Dyett is a graduate of Harvard College.